Venetoclax in Combination With Non-myeloablative Conditioning Allogeneic Haematopoietic Stem Cell Transplantation
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Non-Hodgkin Lymphoma
Related studies linked through entity extraction aliases.
IIT2020-20-SHIRAZIP-WALK: Nature Walks
- Status
- COMPLETED
- Phase
- NA
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid in Combination With Polatuzumab (ViPOR-P) in Relapsed/Refractory B-cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of KB-0742 in Participants With Relapsed or Refractory Solid Tumors Including Platinum Resistant High Grade Serous Ovarian Cancer (HGSOC)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of CTA30X Cell Injection in Patients With Relapsed or Refractory CD19-positive B-line Hematological Malignancies
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Transplantation of Hematopoietic Stem Cells From HLA-compatible Donors in Patients With B-Cell Lymphoid Malignancies
- Status
- WITHDRAWN
- Phase
- PHASE2
huCART19-IL18 in CD19+ Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
SARS-CoV-2 Donor-Recipient Immunity Transfer
- Status
- COMPLETED
- Phase
- N/A
'Re-Priming' RT After Incomplete Response to CAR-T in R/R NHL
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
The clonoSEQ® Watch Registry
- Status
- TERMINATED
- Phase
- N/A
Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Dose-Escalation and Dose-Expansion Study of ZX-101A in Patients With Relapsed/Resistant or Refractory Advanced Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of GS-0189 (Formerly FSI-189) as Monotherapy and in Combination With Rituximab in Participants With Relapsed/Refractory Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Using Romiplostim to Treat Low Platelet Counts Following Chemotherapy and Autologous Hematopoietic Cell Transplantation in People With Blood Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Managing Pain and Symptom Burden Caused by Chemotherapy in People With Myeloma or Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Phase I Study of LP-108 in Patients With Relapsed or Refractory B-cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1
Diet, Physical Activity and Body Composition Changes During R-CHOP
- Status
- WITHDRAWN
- Phase
- N/A
A Study of CTA101 UCAR-T Cell Injection in Patients With Relapsed or Refractory CD19+ B-line Hematological Malignancy
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
The Clinical Study of CD20 CAR-T Cells in Patients With Relapsed and Refractory B Cell Non-Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1